| Revenue | SEK 0 | — |
| EBITDA | SEK -89K | -11% |
| Net profit | SEK -20K | +5% |
| Total assets | SEK 1,8M | -2% |
| Equity | SEK 171K | +88% |
| Employees | 0 | — |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −5 | −6 | −80 | −89 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −5 | −6 | −80 | −89 |
| Net financials | — | −10 | −20 | −20 |
| Profit before tax | −5 | −10 | −21 | −20 |
| Tax | 1 | −0 | −0 | −0 |
| Net profit | −4 | −10 | −21 | −20 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 26 | 492 | 1 822 | 1 785 |
| Equity | 21 | 112 | 91 | 171 |
| Long-term debt | 0 | 366 | 455 | 253 |
| Short-term debt | 5 | 14 | 1 277 | 1 361 |
| Total debt | 5 | 380 | 1 732 | 1 614 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EJ Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
EO Chief Auditor | Chief Auditor | 2022 – 2022 |
SJ Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
| Person | Role here | Other companies |
|---|---|---|
| Erik Oskar Wall | Chief Auditor | 0 companies |
| Erik John-David Larsson | Chief Auditor | 0 companies |
| Sten Johan Pharmanson | Chief Auditor | 0 companies |
| Per-Henrik Roger Karlsson | Deputy Board Member | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Jan Erik Alexander Ranje | Board of Directors | 0 companies |